MersV1, PubMed, Checkpoint, bibRecord, 002294

Synthetic peptides identify promiscuous human Th1 cell epitopes of the secreted mycobacterial antigen MPB70.

Identifieur interne : 002294 ( PubMed/Checkpoint ); précédent : 002293; suivant : 002295

Synthetic peptides identify promiscuous human Th1 cell epitopes of the secreted mycobacterial antigen MPB70.

Auteurs : Raja Al-Attiyah [Koweït] ; Fatema A. Shaban ; Harald G. Wiker ; Fredrik Oftung ; Abu S. Mustafa

Source :

Infection and immunity [ 0019-9567 ] ; 2003.

RBID : pubmed:12654813

Descripteurs français

English descriptors

KwdEn :
- Amino Acid Sequence, Antigens, Bacterial (immunology), BCG Vaccine (immunology), Bacterial Proteins (chemistry), Bacterial Proteins (immunology), CD4-Positive T-Lymphocytes (immunology), Cell Line, Cytotoxicity, Immunologic, Epitope Mapping, Epitopes, T-Lymphocyte, HLA-DR Antigens (metabolism), Humans, Immunodominant Epitopes, Interferon-gamma, Lymphocyte Activation, Molecular Sequence Data, Mycobacterium tuberculosis (immunology), Peptides (chemical synthesis), Peptides (chemistry), Peptides (immunology), Th1 Cells (immunology), Tuberculosis (immunology), Tuberculosis (prevention & control).
MESH :
- chemical , chemical synthesis : Peptides.
- chemical , chemistry : Bacterial Proteins, Peptides.
- chemical , immunology : Antigens, Bacterial, BCG Vaccine, Bacterial Proteins, Peptides.
- immunology : CD4-Positive T-Lymphocytes, Mycobacterium tuberculosis, Th1 Cells, Tuberculosis.
- chemical , metabolism : HLA-DR Antigens.
- prevention & control : Tuberculosis.
- Amino Acid Sequence, Cell Line, Cytotoxicity, Immunologic, Epitope Mapping, Epitopes, T-Lymphocyte, Humans, Immunodominant Epitopes, Interferon-gamma, Lymphocyte Activation, Molecular Sequence Data.

Abstract

MPB70 is a secreted protein of Mycobacterium bovis and Mycobacterium tuberculosis which stimulates both cellular and humoral immune responses during infection with bovine and human tubercle bacilli. In addition, vaccination with MPB70 has been shown to induce Th1 cell responses and protection in animal models of tuberculosis. The present study was carried out to map the dominant human Th1 cell epitopes of MPB70 in relation to major histocompatibility complex (MHC) class II restriction in healthy subjects showing strong T-cell responses to complex mycobacterial antigens. Peripheral blood mononuclear cells (PBMC) from HLA-DR-typed donors were tested with complex mycobacterial antigens (whole-cell M. tuberculosis and M. tuberculosis culture filtrates), with MPB70 purified from the culture filtrate of M. bovis BCG Tokyo, and with 13 synthetic peptides (25-mers overlapping by 10 residues) covering the sequence of MPB70. The donors that responded to the complex antigens and MPB70 also responded to the cocktail of synthetic MPB70 peptides. Testing of PBMC with individual peptides showed that peptides p5 (amino acids [aa] 61 to 85), p6 (aa 76 to 100), p8 (aa 106 to 130), p12 (aa 166 to 190), and p13 (aa 181 to 193) were most frequently recognized in proliferation and gamma interferon (IFN-gamma) assays. Testing of antigen-specific CD4(+) T-cell lines with the individual peptides of MPB70 confirmed that peptides p8, p12, and p13 contain immunodominant Th1 cell epitopes of MPB70. MHC restriction analysis with HLA-typed donors showed that MPB70 and its immunodominant peptides were presented to T cells promiscuously. The T-cell lines responding to MPB70 and peptides p8, p12, and p13 in IFN-gamma assays mediated antigen-peptide-specific cytotoxic activity against monocytes/macrophages pulsed with the whole-protein antigen or the peptides. In conclusion, the promiscuous recognition of MPB70 and its immunodominant peptide defined epitopes (aa 106 to 130 and 166 to 193) by IFN-gamma-producing Th1 cells supports possible application of this secreted antigen to subunit vaccine design.

DOI: 10.1128/iai.71.4.1953-1960.2003
PubMed: 12654813

Affiliations:

Koweït

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: 002462
to stream PubMed, to step Curation: 002462

Links to Exploration step

pubmed:12654813

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Synthetic peptides identify promiscuous human Th1 cell epitopes of the secreted mycobacterial antigen MPB70.</title>
<author><name sortKey="Al Attiyah, Raja" sort="Al Attiyah, Raja" uniqKey="Al Attiyah R" first="Raja" last="Al-Attiyah">Raja Al-Attiyah</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Microbiology, Faculty of Medicine, Kuwait University, PO Box 24923, Safat 13110, Kuwait. rj-alattiyah@hsc.kuniv.edu.kw</nlm:affiliation>
<country xml:lang="fr">Koweït</country>
<wicri:regionArea>Department of Microbiology, Faculty of Medicine, Kuwait University, PO Box 24923, Safat 13110</wicri:regionArea>
<wicri:noRegion>Safat 13110</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Shaban, Fatema A" sort="Shaban, Fatema A" uniqKey="Shaban F" first="Fatema A" last="Shaban">Fatema A. Shaban</name>
</author>
<author><name sortKey="Wiker, Harald G" sort="Wiker, Harald G" uniqKey="Wiker H" first="Harald G" last="Wiker">Harald G. Wiker</name>
</author>
<author><name sortKey="Oftung, Fredrik" sort="Oftung, Fredrik" uniqKey="Oftung F" first="Fredrik" last="Oftung">Fredrik Oftung</name>
</author>
<author><name sortKey="Mustafa, Abu S" sort="Mustafa, Abu S" uniqKey="Mustafa A" first="Abu S" last="Mustafa">Abu S. Mustafa</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2003">2003</date>
<idno type="RBID">pubmed:12654813</idno>
<idno type="pmid">12654813</idno>
<idno type="doi">10.1128/iai.71.4.1953-1960.2003</idno>
<idno type="wicri:Area/PubMed/Corpus">002462</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002462</idno>
<idno type="wicri:Area/PubMed/Curation">002462</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002462</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002294</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002294</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Synthetic peptides identify promiscuous human Th1 cell epitopes of the secreted mycobacterial antigen MPB70.</title>
<author><name sortKey="Al Attiyah, Raja" sort="Al Attiyah, Raja" uniqKey="Al Attiyah R" first="Raja" last="Al-Attiyah">Raja Al-Attiyah</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Microbiology, Faculty of Medicine, Kuwait University, PO Box 24923, Safat 13110, Kuwait. rj-alattiyah@hsc.kuniv.edu.kw</nlm:affiliation>
<country xml:lang="fr">Koweït</country>
<wicri:regionArea>Department of Microbiology, Faculty of Medicine, Kuwait University, PO Box 24923, Safat 13110</wicri:regionArea>
<wicri:noRegion>Safat 13110</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Shaban, Fatema A" sort="Shaban, Fatema A" uniqKey="Shaban F" first="Fatema A" last="Shaban">Fatema A. Shaban</name>
</author>
<author><name sortKey="Wiker, Harald G" sort="Wiker, Harald G" uniqKey="Wiker H" first="Harald G" last="Wiker">Harald G. Wiker</name>
</author>
<author><name sortKey="Oftung, Fredrik" sort="Oftung, Fredrik" uniqKey="Oftung F" first="Fredrik" last="Oftung">Fredrik Oftung</name>
</author>
<author><name sortKey="Mustafa, Abu S" sort="Mustafa, Abu S" uniqKey="Mustafa A" first="Abu S" last="Mustafa">Abu S. Mustafa</name>
</author>
</analytic>
<series><title level="j">Infection and immunity</title>
<idno type="ISSN">0019-9567</idno>
<imprint><date when="2003" type="published">2003</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Amino Acid Sequence</term>
<term>Antigens, Bacterial (immunology)</term>
<term>BCG Vaccine (immunology)</term>
<term>Bacterial Proteins (chemistry)</term>
<term>Bacterial Proteins (immunology)</term>
<term>CD4-Positive T-Lymphocytes (immunology)</term>
<term>Cell Line</term>
<term>Cytotoxicity, Immunologic</term>
<term>Epitope Mapping</term>
<term>Epitopes, T-Lymphocyte</term>
<term>HLA-DR Antigens (metabolism)</term>
<term>Humans</term>
<term>Immunodominant Epitopes</term>
<term>Interferon-gamma</term>
<term>Lymphocyte Activation</term>
<term>Molecular Sequence Data</term>
<term>Mycobacterium tuberculosis (immunology)</term>
<term>Peptides (chemical synthesis)</term>
<term>Peptides (chemistry)</term>
<term>Peptides (immunology)</term>
<term>Th1 Cells (immunology)</term>
<term>Tuberculosis (immunology)</term>
<term>Tuberculosis (prevention & control)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Activation des lymphocytes</term>
<term>Antigènes HLA-DR (métabolisme)</term>
<term>Antigènes bactériens (immunologie)</term>
<term>Cartographie épitopique</term>
<term>Cytotoxicité immunologique</term>
<term>Données de séquences moléculaires</term>
<term>Déterminants antigéniques des lymphocytes T</term>
<term>Humains</term>
<term>Interféron gamma</term>
<term>Lignée cellulaire</term>
<term>Lymphocytes T CD4+ (immunologie)</term>
<term>Lymphocytes auxiliaires Th1 (immunologie)</term>
<term>Mycobacterium tuberculosis (immunologie)</term>
<term>Peptides ()</term>
<term>Peptides (immunologie)</term>
<term>Peptides (synthèse chimique)</term>
<term>Protéines bactériennes ()</term>
<term>Protéines bactériennes (immunologie)</term>
<term>Séquence d'acides aminés</term>
<term>Tuberculose ()</term>
<term>Tuberculose (immunologie)</term>
<term>Vaccin BCG (immunologie)</term>
<term>Épitopes immunodominants</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemical synthesis" xml:lang="en"><term>Peptides</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en"><term>Bacterial Proteins</term>
<term>Peptides</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>Antigens, Bacterial</term>
<term>BCG Vaccine</term>
<term>Bacterial Proteins</term>
<term>Peptides</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Antigènes bactériens</term>
<term>Lymphocytes T CD4+</term>
<term>Lymphocytes auxiliaires Th1</term>
<term>Mycobacterium tuberculosis</term>
<term>Peptides</term>
<term>Protéines bactériennes</term>
<term>Tuberculose</term>
<term>Vaccin BCG</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>CD4-Positive T-Lymphocytes</term>
<term>Mycobacterium tuberculosis</term>
<term>Th1 Cells</term>
<term>Tuberculosis</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>HLA-DR Antigens</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Antigènes HLA-DR</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Tuberculosis</term>
</keywords>
<keywords scheme="MESH" qualifier="synthèse chimique" xml:lang="fr"><term>Peptides</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Amino Acid Sequence</term>
<term>Cell Line</term>
<term>Cytotoxicity, Immunologic</term>
<term>Epitope Mapping</term>
<term>Epitopes, T-Lymphocyte</term>
<term>Humans</term>
<term>Immunodominant Epitopes</term>
<term>Interferon-gamma</term>
<term>Lymphocyte Activation</term>
<term>Molecular Sequence Data</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Activation des lymphocytes</term>
<term>Cartographie épitopique</term>
<term>Cytotoxicité immunologique</term>
<term>Données de séquences moléculaires</term>
<term>Déterminants antigéniques des lymphocytes T</term>
<term>Humains</term>
<term>Interféron gamma</term>
<term>Lignée cellulaire</term>
<term>Peptides</term>
<term>Protéines bactériennes</term>
<term>Séquence d'acides aminés</term>
<term>Tuberculose</term>
<term>Épitopes immunodominants</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">MPB70 is a secreted protein of Mycobacterium bovis and Mycobacterium tuberculosis which stimulates both cellular and humoral immune responses during infection with bovine and human tubercle bacilli. In addition, vaccination with MPB70 has been shown to induce Th1 cell responses and protection in animal models of tuberculosis. The present study was carried out to map the dominant human Th1 cell epitopes of MPB70 in relation to major histocompatibility complex (MHC) class II restriction in healthy subjects showing strong T-cell responses to complex mycobacterial antigens. Peripheral blood mononuclear cells (PBMC) from HLA-DR-typed donors were tested with complex mycobacterial antigens (whole-cell M. tuberculosis and M. tuberculosis culture filtrates), with MPB70 purified from the culture filtrate of M. bovis BCG Tokyo, and with 13 synthetic peptides (25-mers overlapping by 10 residues) covering the sequence of MPB70. The donors that responded to the complex antigens and MPB70 also responded to the cocktail of synthetic MPB70 peptides. Testing of PBMC with individual peptides showed that peptides p5 (amino acids [aa] 61 to 85), p6 (aa 76 to 100), p8 (aa 106 to 130), p12 (aa 166 to 190), and p13 (aa 181 to 193) were most frequently recognized in proliferation and gamma interferon (IFN-gamma) assays. Testing of antigen-specific CD4(+) T-cell lines with the individual peptides of MPB70 confirmed that peptides p8, p12, and p13 contain immunodominant Th1 cell epitopes of MPB70. MHC restriction analysis with HLA-typed donors showed that MPB70 and its immunodominant peptides were presented to T cells promiscuously. The T-cell lines responding to MPB70 and peptides p8, p12, and p13 in IFN-gamma assays mediated antigen-peptide-specific cytotoxic activity against monocytes/macrophages pulsed with the whole-protein antigen or the peptides. In conclusion, the promiscuous recognition of MPB70 and its immunodominant peptide defined epitopes (aa 106 to 130 and 166 to 193) by IFN-gamma-producing Th1 cells supports possible application of this secreted antigen to subunit vaccine design.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">12654813</PMID>
<DateCompleted><Year>2003</Year>
<Month>05</Month>
<Day>12</Day>
</DateCompleted>
<DateRevised><Year>2019</Year>
<Month>05</Month>
<Day>08</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">0019-9567</ISSN>
<JournalIssue CitedMedium="Print"><Volume>71</Volume>
<Issue>4</Issue>
<PubDate><Year>2003</Year>
<Month>Apr</Month>
</PubDate>
</JournalIssue>
<Title>Infection and immunity</Title>
<ISOAbbreviation>Infect. Immun.</ISOAbbreviation>
</Journal>
<ArticleTitle>Synthetic peptides identify promiscuous human Th1 cell epitopes of the secreted mycobacterial antigen MPB70.</ArticleTitle>
<Pagination><MedlinePgn>1953-60</MedlinePgn>
</Pagination>
<Abstract><AbstractText>MPB70 is a secreted protein of Mycobacterium bovis and Mycobacterium tuberculosis which stimulates both cellular and humoral immune responses during infection with bovine and human tubercle bacilli. In addition, vaccination with MPB70 has been shown to induce Th1 cell responses and protection in animal models of tuberculosis. The present study was carried out to map the dominant human Th1 cell epitopes of MPB70 in relation to major histocompatibility complex (MHC) class II restriction in healthy subjects showing strong T-cell responses to complex mycobacterial antigens. Peripheral blood mononuclear cells (PBMC) from HLA-DR-typed donors were tested with complex mycobacterial antigens (whole-cell M. tuberculosis and M. tuberculosis culture filtrates), with MPB70 purified from the culture filtrate of M. bovis BCG Tokyo, and with 13 synthetic peptides (25-mers overlapping by 10 residues) covering the sequence of MPB70. The donors that responded to the complex antigens and MPB70 also responded to the cocktail of synthetic MPB70 peptides. Testing of PBMC with individual peptides showed that peptides p5 (amino acids [aa] 61 to 85), p6 (aa 76 to 100), p8 (aa 106 to 130), p12 (aa 166 to 190), and p13 (aa 181 to 193) were most frequently recognized in proliferation and gamma interferon (IFN-gamma) assays. Testing of antigen-specific CD4(+) T-cell lines with the individual peptides of MPB70 confirmed that peptides p8, p12, and p13 contain immunodominant Th1 cell epitopes of MPB70. MHC restriction analysis with HLA-typed donors showed that MPB70 and its immunodominant peptides were presented to T cells promiscuously. The T-cell lines responding to MPB70 and peptides p8, p12, and p13 in IFN-gamma assays mediated antigen-peptide-specific cytotoxic activity against monocytes/macrophages pulsed with the whole-protein antigen or the peptides. In conclusion, the promiscuous recognition of MPB70 and its immunodominant peptide defined epitopes (aa 106 to 130 and 166 to 193) by IFN-gamma-producing Th1 cells supports possible application of this secreted antigen to subunit vaccine design.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Al-Attiyah</LastName>
<ForeName>Raja</ForeName>
<Initials>R</Initials>
<AffiliationInfo><Affiliation>Department of Microbiology, Faculty of Medicine, Kuwait University, PO Box 24923, Safat 13110, Kuwait. rj-alattiyah@hsc.kuniv.edu.kw</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Shaban</LastName>
<ForeName>Fatema A</ForeName>
<Initials>FA</Initials>
</Author>
<Author ValidYN="Y"><LastName>Wiker</LastName>
<ForeName>Harald G</ForeName>
<Initials>HG</Initials>
</Author>
<Author ValidYN="Y"><LastName>Oftung</LastName>
<ForeName>Fredrik</ForeName>
<Initials>F</Initials>
</Author>
<Author ValidYN="Y"><LastName>Mustafa</LastName>
<ForeName>Abu S</ForeName>
<Initials>AS</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Infect Immun</MedlineTA>
<NlmUniqueID>0246127</NlmUniqueID>
<ISSNLinking>0019-9567</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000942">Antigens, Bacterial</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D001500">BCG Vaccine</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D001426">Bacterial Proteins</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D018984">Epitopes, T-Lymphocyte</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D006684">HLA-DR Antigens</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D016056">Immunodominant Epitopes</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D010455">Peptides</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>123338-23-8</RegistryNumber>
<NameOfSubstance UI="C060216">MPB70 protein, Mycobacterium bovis</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>82115-62-6</RegistryNumber>
<NameOfSubstance UI="D007371">Interferon-gamma</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000942" MajorTopicYN="N">Antigens, Bacterial</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D001500" MajorTopicYN="N">BCG Vaccine</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D001426" MajorTopicYN="N">Bacterial Proteins</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015496" MajorTopicYN="N">CD4-Positive T-Lymphocytes</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003602" MajorTopicYN="N">Cytotoxicity, Immunologic</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018604" MajorTopicYN="Y">Epitope Mapping</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018984" MajorTopicYN="Y">Epitopes, T-Lymphocyte</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006684" MajorTopicYN="N">HLA-DR Antigens</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016056" MajorTopicYN="N">Immunodominant Epitopes</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007371" MajorTopicYN="N">Interferon-gamma</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008213" MajorTopicYN="N">Lymphocyte Activation</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008969" MajorTopicYN="N">Molecular Sequence Data</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009169" MajorTopicYN="N">Mycobacterium tuberculosis</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D010455" MajorTopicYN="N">Peptides</DescriptorName>
<QualifierName UI="Q000138" MajorTopicYN="Y">chemical synthesis</QualifierName>
<QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018417" MajorTopicYN="N">Th1 Cells</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014376" MajorTopicYN="N">Tuberculosis</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year>
<Month>3</Month>
<Day>26</Day>
<Hour>5</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2003</Year>
<Month>5</Month>
<Day>13</Day>
<Hour>5</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2003</Year>
<Month>3</Month>
<Day>26</Day>
<Hour>5</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">12654813</ArticleId>
<ArticleId IdType="pmc">PMC152036</ArticleId>
<ArticleId IdType="doi">10.1128/iai.71.4.1953-1960.2003</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Infect Immun. 1999 Nov;67(11):5683-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10531216</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Scand J Immunol. 2003 Feb;57(2):151-61</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12588661</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Eur J Immunol. 2000 May;30(5):1512-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10820400</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dis. 2000 May;181(5):1850-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10823800</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Infect Immun. 2000 Jul;68(7):3933-40</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10858206</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 2000 Jun;30 Suppl 3:S291-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10875803</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dis. 2000 Sep;182(3):895-901</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10950786</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Eur J Immunol. 2000 Sep;30(9):2713-21</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11009107</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Infect Immun. 1981 Mar;31(3):1152-60</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7014457</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Infect Immun. 1983 Feb;39(2):540-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">6339381</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Exp Immunol. 1983 Apr;52(1):29-37</Citation>
<ArticleIdList><ArticleId IdType="pubmed">6190596</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am Rev Respir Dis. 1984 Mar;129(3):444-52</Citation>
<ArticleIdList><ArticleId IdType="pubmed">6367574</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lepr Rev. 1986 Dec;57 Suppl 2:123-30</Citation>
<ArticleIdList><ArticleId IdType="pubmed">3106732</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Exp Immunol. 1987 Aug;69(2):255-62</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2958195</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Scand J Immunol. 1988 Feb;27(2):187-94</Citation>
<ArticleIdList><ArticleId IdType="pubmed">3124263</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Lepr Other Mycobact Dis. 1988 Jun;56(2):265-73</Citation>
<ArticleIdList><ArticleId IdType="pubmed">3045224</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Immunol. 1988 Oct 15;141(8):2749-54</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2459228</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 1997 Jun 13;276(5319):1684-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9180075</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Infect Immun. 1998 Jan;66(1):176-80</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9423855</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Infect Immun. 1998 Feb;66(2):830-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9453650</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Infect Immun. 1998 Apr;66(4):1445-52</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9529066</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>FEMS Immunol Med Microbiol. 1998 Mar;20(3):231-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9566494</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Scand J Immunol. 1998 Jul;48(1):44-51</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9714409</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Scand J Immunol. 1998 Nov;48(5):535-43</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9822264</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Eur J Immunol. 1998 Dec;28(12):3949-58</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9862331</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Immunology. 1998 Dec;95(4):585-90</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9893049</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dis. 1999 Mar;179(3):637-45</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9952370</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>FEMS Immunol Med Microbiol. 1999 Jun;24(2):151-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10378414</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Diagn Lab Immunol. 1999 Sep;6(5):675-82</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10473516</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA. 1999 Aug 18;282(7):677-86</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10517722</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Eur J Immunol. 2000 Jun;30(6):1724-32</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10898510</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Lepr Other Mycobact Dis. 1989 Mar;57(1):1-11</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2659694</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>FEMS Microbiol Lett. 1989 Apr;49(2-3):273-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2663636</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Immunol. 1990 Feb 15;144(4):1478-83</Citation>
<ArticleIdList><ArticleId IdType="pubmed">1689354</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Microbiol. 1990 May;28(5):913-21</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2191012</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Infect Immun. 1991 Jan;59(1):372-82</Citation>
<ArticleIdList><ArticleId IdType="pubmed">1898899</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Immunol Cell Biol. 1990 Dec;68 ( Pt 6):359-65</Citation>
<ArticleIdList><ArticleId IdType="pubmed">1711006</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Tissue Antigens. 1993 Jan;41(1):55-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8456444</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Immunol. 1993 Jul 1;151(1):518-25</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8100846</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Infect Immun. 1993 Aug;61(8):3482-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8335379</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Eur J Immunol. 1993 Sep;23(9):2189-95</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8103743</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Infect Immun. 1993 Dec;61(12):5294-301</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8225603</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Exp Med. 1993 Dec 1;178(6):2249-54</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7504064</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Immunology. 1994 May;82(1):9-15</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7519175</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Infect Immun. 1994 Dec;62(12):5411-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7525484</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Infect Immun. 1994 Dec;62(12):5595-602</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7525488</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dis. 1994 Nov;170(5):1326-30</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7963739</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Kekkaku. 1994 Oct;69(10):607-13</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7799571</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Scand J Immunol. 1995 Mar;41(3):281-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7871388</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 1995 Nov 18;346(8986):1339-45</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7475776</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Immunology. 1996 Mar;87(3):421-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8778028</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Lepr Other Mycobact Dis. 1996 Sep;64(3):257-67</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8862259</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Scand J Immunol. 1997 Feb;45(2):115-31</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9042423</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dis. 2001 Feb 1;183(3):469-77</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11133379</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2001 Jun 23;357(9273):2017-21</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11438135</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Curr Pharm Biotechnol. 2001 Jun;2(2):157-73</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11480420</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Immunol. 2001 Dec 15;167(12):6991-7000</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11739519</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Exp Immunol. 2002 Oct;130(1):37-42</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12296851</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Tuber Lung Dis. 1999;79(4):243-50</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10692993</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Koweït</li>
</country>
</list>
<tree><noCountry><name sortKey="Mustafa, Abu S" sort="Mustafa, Abu S" uniqKey="Mustafa A" first="Abu S" last="Mustafa">Abu S. Mustafa</name>
<name sortKey="Oftung, Fredrik" sort="Oftung, Fredrik" uniqKey="Oftung F" first="Fredrik" last="Oftung">Fredrik Oftung</name>
<name sortKey="Shaban, Fatema A" sort="Shaban, Fatema A" uniqKey="Shaban F" first="Fatema A" last="Shaban">Fatema A. Shaban</name>
<name sortKey="Wiker, Harald G" sort="Wiker, Harald G" uniqKey="Wiker H" first="Harald G" last="Wiker">Harald G. Wiker</name>
</noCountry>
<country name="Koweït"><noRegion><name sortKey="Al Attiyah, Raja" sort="Al Attiyah, Raja" uniqKey="Al Attiyah R" first="Raja" last="Al-Attiyah">Raja Al-Attiyah</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/PubMed/Checkpoint

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002294 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 002294 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    MersV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    RBID
   |clé=     pubmed:12654813
   |texte=   Synthetic peptides identify promiscuous human Th1 cell epitopes of the secreted mycobacterial antigen MPB70.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i   -Sk "pubmed:12654813" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd   \
       | NlmPubMed2Wicri -a MersV1

This area was generated with Dilib version V0.6.33.
Data generation: Mon Apr 20 23:26:43 2020. Site generation: Sat Mar 27 09:06:09 2021

	Serveur d'exploration MERS
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration MERS

Synthetic peptides identify promiscuous human Th1 cell epitopes of the secreted mycobacterial antigen MPB70.

Synthetic peptides identify promiscuous human Th1 cell epitopes of the secreted mycobacterial antigen MPB70.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki